Business
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against First Choice Healthcare Solutions, Inc.
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against First Choice Healthcare Solutions, Inc..
About this update from First Choice Healthcare Solutions, Inc.
[{"type":"text","content":"\nWILMINGTON, Del., April 10, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:\n Do you, or did you, own shares of First Choice Healthcare Solutions, Inc. (OTC QB: FCHS)? Did you purchase your shares between April 1, 2014 and November 14, 2018, inclusive? Did you lose money in your investment? Rigrodsky & Long, P.A. announces that a complaint has been filed in the United States District Court for the Middle District of Florida on behalf of all persons or entities that purchased the common stock of First Choice Healthcare Solutions, Inc. (“First Choice” or the “Company”) (OTC QB: FCHS) between April 1, 2014 and November 14, 2018, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”). If you purchased shares of First Choice during the Class Period, or purchased shares prior to the Class Period and still hold First Choice, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Seth D. Rigrodsky or Timothy J. MacFall at Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington, DE 19801, by telephone at (888) 969-4242, by e-mail at [email protected], or at http://rigrodskylong.com/contact-us/.                                    The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects.  Specifically, the Complaint alleges that the defendants concealed from the investing public that: (i) Defendants retained Elite Stock Research to falsely promote the Company to investors in order to materially inflate the price of First Choice stock; (ii) the Company, through Romandetti, participated in a scheme to materially inflate the price of First Choice through an unlawful, paid promotional campaign, which enabled Romandetti to personally profit from the scheme; (iii) Defendants were in violation of the Company’s internal compliance policies including its Compliance Pr...